Zentalis Pharmaceuticals (ZNTL) Intangibles (2019 - 2021)
Zentalis Pharmaceuticals (ZNTL) posted quarterly Intangibles of $8.8 million for Q2 2021, little changed year-over-year from $8.8 million in Q2 2020, and little changed quarter-over-quarter from $8.8 million in Q1 2021.
Zentalis Pharmaceuticals (ZNTL) Intangibles (2019 - 2021) Analysis & Trends
Zentalis Pharmaceuticals' Intangibles history runs 3 years deep, the most recent figure standing at $8.8 million for Q2 2021.
- In Q2 2021, Intangibles changed 0.0% year-over-year to $8.8 million; the TTM figure through Jun 2021 stood at $8.8 million (changed 0.0% YoY), while the FY2020 annual figure was $8.8 million, changed 0.0% from the prior year.
- Intangibles for Q2 2021 stood at $8.8 million, roughly flat from $8.8 million in the prior quarter.
- The five-year high for Intangibles was $8.8 million in Q4 2019, with the low at $8.8 million in Q4 2019.
- The 3-year median for Intangibles is $8.8 million (2019), against an average of $8.8 million.
- Peak annual rise in Intangibles reached 0.0% in 2020, while the deepest fall reached 0.0% in 2020.
- Zentalis Pharmaceuticals' Intangibles stood at $8.8 million in 2019, then changed by 0.0% to $8.8 million in 2020, then changed by 0.0% to $8.8 million in 2021.
- Business Quant data shows ZNTL's Intangibles at $8.8 million in Q2 2021, $8.8 million in Q1 2021, and $8.8 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Zentalis Pharmaceuticals | 255.14 Mn | 255.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 8.80 Mn |
| Mar 31, 2021 | 8.80 Mn |
| Dec 31, 2020 | 8.80 Mn |
| Sep 30, 2020 | 8.80 Mn |
| Jun 30, 2020 | 8.80 Mn |
| Mar 31, 2020 | 8.80 Mn |
| Dec 31, 2019 | 8.80 Mn |